Pancreatic cancer: drug cocktail improves survival - latimes.com
Links shared publicly online about this topic.
- 300total visits
Pancreatic cancer: drug cocktail improves survival - latimes.com
View full resource at latimes.com
Tags: Pancreatic Disease, Cancer, Cancer Medication, Chemotherapy, Colorectal Cancer Medication, Pancreatic Cancer, Drug
Most Recently Shared on May 12, 2011 at 2:48 am By:
Cocktail of chemotherapy drugs improves survival with pancreatic cancer: A cocktail of four chemotherapy drugs i... http://lat.ms/l1RB7b
Symposier - Dr. Chabot Discusses Pancreatic Cancer Chemotherapy
symposier.com — “Uploaded and shared in Youtube by: OncLiveTV — John Chabot, MD, chief, division of GI/Endocrine Surgery, executive director, Pancreas Center at New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, discusses the current chemotherapy options available to treat pancreatic cancer. The main drug available is gemcitabine and is currently used in combination therapies. There are currently trials underway that are demonstrating improved survival with aggressive chemotherapy.” View full resource at symposier.com
Most Recently Shared on August 30, 2011 at 5:24 pm By:
Symposier Endocrino Health Site
Dr. Chabot Discusses Pancreatic Cancer Chemotherapy. http://t.co/EAJX9HR
Multiple epidemiological parameters drive increase in drug-treatment opportunities for pancreatic cancer: Decision Resources
news-medical.net — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds significant trends in multiple epidemiological parameters to be driving the increase in drug-treatment opportunities for pancreatic cancer over the period 2009 to 2024, including population aging, increasing risk of recurrence following resection and modest improvements in survival.” View full resource at news-medical.net
Most Recently Shared on November 18, 2010 at 2:23 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Multiple epidemiological parameters drive increase in drug-treatment opportunities for pancreatic... http://bit.ly/aVPeSF
Medical News: Adjuvant Chemo Drugs Equal for Pancreatic Cancer - in Oncology, Chemotherapy from MedPage Today
medpagetoday.com — “Gemcitabine (Gemzar) doesn't improve survival in patients with resected pancreatic cancer compared with other chemotherapy, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on September 8, 2010 at 1:20 pm By:
Drugs and Devices OW OW Health
Adjuvant Chemo Drugs Equal for Pancreatic Cancer: Gemcitabine (Gemzar) doesn't improve survival in patients w... http://bit.ly/duvekq #drug
Pancreatic Chemo Comparison Finds No Survival Boost - Drugs.com MedNews
drugs.com — “Pancreatic cancer patients undergoing chemotherapy after surgery don t see improved long-term survival with the drug gemcitabine, compared with patients receivi” View full resource at drugs.com
Most Recently Shared on September 7, 2010 at 11:23 pm By:
Drugs and Devices OW OW Health
Pancreatic Chemo Comparison Finds No Survival Boost: TUESDAY, Sept. 7 -- Pancreatic cancer patients undergoin... http://bit.ly/dpLBCc #drug
Pancreatic Chemo Comparison Finds No Survival Boost - Drugs.com MedNews
drugs.com — “Pancreatic cancer patients undergoing chemotherapy after surgery don t see improved long-term survival with the drug gemcitabine, compared with patients receivi” View full resource at drugs.com
Most Recently Shared on September 7, 2010 at 11:19 pm By:
Pancreatic Chemo Comparison Finds No Survival Boost - http://bit.ly/chk7NH
Drug Combination Improves Survival in Pancreatic Cancer
clinicaloncology.com — “Drug Combination Improves Survival in Pancreatic Cancer Clinicians have a new regimen to consider for the first-line treatment of certain patients with metastatic pancreatic cancer. First-line therapy with FOLFIRINOX, a combination of older chemotherapeutic drugs, improved median overall survival (OS) of certain patients with pancreatic cancer by four months (11.1 vs. 6.8 months) compared with gemcitabine (Gemzar, Eli Lilly). Kate O'Rourke” View full resource at clinicaloncology.com
Most Recently Shared on August 11, 2010 at 9:55 pm By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Drug Combination Improves Survival in Pancreatic Cancer http://ow.ly/2ojbt
Amgen - Media - Press Release
amgen.com — “Amgen - Media - Press Release” View full resource at amgen.com
Most Recently Shared on June 4, 2010 at 8:58 pm By:
Amgen's Pancreatic Cancer Drug Improves Survival Rate Over Gemcitabine - Also improves survival-free progression http://bit.ly/c54eDZ
Advertisement
